Literature DB >> 17619810

The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab.

B Mayrbaeurl, M Hinterreiter, S Burgstaller, M Windpessl, J Thaler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17619810     DOI： 10.1007/s10067-007-0684-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

Review 1.  Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis.

Authors:  A Bhatia; P J Ell; J C W Edwards
Journal:  Ann Rheum Dis       Date:  2005-07       Impact factor: 19.103

2.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

3.  T cell activation in rheumatoid synovium is B cell dependent.

Authors:  S Takemura; P A Klimiuk; A Braun; J J Goronzy; C M Weyand
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

Review 4.  The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets.

Authors:  Thomas Dörner; Gerd R Burmester
Journal:  Curr Opin Rheumatol       Date:  2003-05       Impact factor: 5.006

5.  Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

Authors:  J A Jover; C Hernández-García; I C Morado; E Vargas; A Bañares; B Fernández-Gutiérrez
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

6.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors:  Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245

Review 7.  Giant-cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

8.  Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

Authors:  M J van der Veen; H J Dinant; C van Booma-Frankfort; G A van Albada-Kuipers; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103
  8 in total
  8 in total

Review 1.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 2.  Giant cell arteritis: a review.

Authors:  Pravin Patil; Niral Karia; Shaifali Jain; Bhaskar Dasgupta
Journal:  Eye Brain       Date:  2013-03-09

Review 3.  Update on the management of giant cell arteritis.

Authors:  Janet Roberts; Alison Clifford
Journal:  Ther Adv Chronic Dis       Date:  2017-03-28       Impact factor: 5.091

4.  Unmasking the elusive giant: an unusual case presenting as third nerve palsy in a patient with scleroderma.

Authors:  Wan Lin Ng; John McManus; James Anthony Joseph Devlin; Alexander Fraser
Journal:  BMJ Case Rep       Date:  2016-04-11

Review 5.  Giant Cell Arteritis: Beyond Corticosteroids.

Authors:  Lauren Steel; Asad Khan; Bhaskar Dasgupta
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

Review 6.  Co-Presentation of Giant Cell Arteritis and Granulomatosis with Polyangiitis: A Case Report and Review of Literature.

Authors:  Haitham H Hassane; Mirza M Beg; Chokkalingam Siva; Celso Velázquez
Journal:  Am J Case Rep       Date:  2018-06-06

Review 7.  Biologic Therapies for Giant Cell Arteritis.

Authors:  Robert Harrington; Shamma Ahmad Al Nokhatha; Richard Conway
Journal:  Biologics       Date:  2021-01-06

Review 8.  Need and value of targeted immunosuppressive therapy in giant cell arteritis.

Authors:  Maria Sandovici; Niels van der Geest; Yannick van Sleen; Elisabeth Brouwer
Journal:  RMD Open       Date:  2022-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.